Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2021

01-12-2021 | Giant Cell Arteritis | Review

Coronary artery vasculitis: a review of current literature

Authors: Shaun Khanna, Kartheek Garikapati, Daniel S. L. Goh, Kenneth Cho, Phillip Lo, Mohan V. Bhojaraja, Surjit Tarafdar

Published in: BMC Cardiovascular Disorders | Issue 1/2021

Login to get access

Abstract

Cardiac vasculitis is recognized as a heterogeneous disease process with a wide spectrum of manifestations including pericarditis, myocarditis, valvular heart disease and less frequently, coronary artery vasculitis (CAV). CAV encompasses an emerging field of diseases which differ from conventional atherosclerotic disease and have a proclivity for the younger population groups. CAV portends multiple complications including the development of coronary artery aneurysms, coronary stenotic lesions, and thrombosis, all which may result in acute coronary syndromes. There are several aetiologies for CAV; with Kawasaki’s disease, Takayasu's arteritis, Polyarteritis Nodosa, and Giant-Cell Arteritis more frequently described clinically, and in literature. There is a growing role for multi-modality imaging in assisting the diagnostic process; including transthoracic echocardiography, cardiac magnetic resonance imaging, computed tomography coronary angiography, fluorodeoxyglucose-positron emission tomography and conventional coronary angiogram with intravascular ultrasound. Whilst the treatment paradigms fundamentally vary between different aetiologies, there are overlaps with pharmacological regimes in immunosuppressive agents and anti-platelet therapies. Interventional and surgical management are is a consideration in select populations groups, within a multi-disciplinary context. Further large-scale studies are required to better appropriately outline management protocols in this niche population.
Literature
1.
go back to reference Farrah TE, Basu N, Dweck M, Calcagno C, Fayad ZA, Dhaun N. Advances in therapies and imaging for systemic vasculitis. Arterioscler Thromb Vasc Biol. 2019;39(8):1520–41.PubMedCrossRef Farrah TE, Basu N, Dweck M, Calcagno C, Fayad ZA, Dhaun N. Advances in therapies and imaging for systemic vasculitis. Arterioscler Thromb Vasc Biol. 2019;39(8):1520–41.PubMedCrossRef
3.
go back to reference Miloslavsky E, Unizony S. The heart in vasculitis. Rheum Dis Clin. 2014;40(1):11–26.CrossRef Miloslavsky E, Unizony S. The heart in vasculitis. Rheum Dis Clin. 2014;40(1):11–26.CrossRef
4.
go back to reference Stvrtinova V. Vasculitides of the coronary arteries. Bratisl Lek Listy. 1995;96(10):544–51.PubMed Stvrtinova V. Vasculitides of the coronary arteries. Bratisl Lek Listy. 1995;96(10):544–51.PubMed
5.
go back to reference Kinno M, Mathenge N, Patel M, Niazi O, Lichtenstein SJ, Tariq U, et al. Isolated coronary vasculitis as a cause of acute myocardial infarction: a diagnostic dilemma. J Am Coll Cardiol. 2016;67(13 Supplement):1156.CrossRef Kinno M, Mathenge N, Patel M, Niazi O, Lichtenstein SJ, Tariq U, et al. Isolated coronary vasculitis as a cause of acute myocardial infarction: a diagnostic dilemma. J Am Coll Cardiol. 2016;67(13 Supplement):1156.CrossRef
6.
go back to reference Waller BF, Fry ET, Hermiller JB, Peters T, Slack JD. Nonatherosclerotic causes of coronary artery narrowing—Part I. Clin Cardiol. 1996;19(6):509–12.PubMedCrossRef Waller BF, Fry ET, Hermiller JB, Peters T, Slack JD. Nonatherosclerotic causes of coronary artery narrowing—Part I. Clin Cardiol. 1996;19(6):509–12.PubMedCrossRef
7.
go back to reference Mavrogeni S, Cantini F, Pohost GM. Systemic vasculitis: an underestimated cause of heart failure—assessment by cardiovascular magnetic resonance. Rev Cardiovasc Med. 2019;14(1):49–55. Mavrogeni S, Cantini F, Pohost GM. Systemic vasculitis: an underestimated cause of heart failure—assessment by cardiovascular magnetic resonance. Rev Cardiovasc Med. 2019;14(1):49–55.
8.
go back to reference Mavrogeni S. Cardiac involvement in small and medium sized vasculitides. Eur Soc Cardiol. 2007;6:14. Mavrogeni S. Cardiac involvement in small and medium sized vasculitides. Eur Soc Cardiol. 2007;6:14.
9.
go back to reference Watts RA, Mahr A, Mohammad AJ, Gatenby P, Basu N, Flores-Suárez LF. Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Nephrol Dial Transpl. 2015;30(suppl_1):14–22.CrossRef Watts RA, Mahr A, Mohammad AJ, Gatenby P, Basu N, Flores-Suárez LF. Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Nephrol Dial Transpl. 2015;30(suppl_1):14–22.CrossRef
10.
go back to reference Villatoro-Villar M, Bold MS, Warrington KJ, Crowson CS, Goyal G, Shah M, et al. Arterial involvement in Erdheim-Chester disease: a retrospective cohort study. Medicine. 2018;97(49):e13452.PubMedPubMedCentralCrossRef Villatoro-Villar M, Bold MS, Warrington KJ, Crowson CS, Goyal G, Shah M, et al. Arterial involvement in Erdheim-Chester disease: a retrospective cohort study. Medicine. 2018;97(49):e13452.PubMedPubMedCentralCrossRef
11.
go back to reference Merkel PA, Matteson ELE, Curtis MRE. Clinical features and diagnosis of Takayasu arteritis. UpToDate, Waltham, MA. Last accessed 07 April 2020. Merkel PA, Matteson ELE, Curtis MRE. Clinical features and diagnosis of Takayasu arteritis. UpToDate, Waltham, MA. Last accessed 07 April 2020.
13.
go back to reference Dye JR, Kaul MS, St. Clair EW. Inflammatory diseases of the coronary arteries. In: Lanzer P, editor. PanVascular Medicine. Berlin: Springer; 2013. p. 1–40. Dye JR, Kaul MS, St. Clair EW. Inflammatory diseases of the coronary arteries. In: Lanzer P, editor. PanVascular Medicine. Berlin: Springer; 2013. p. 1–40.
15.
go back to reference Zimba O, editor. Cardiac involvement in systemic vasculitis: a retrospective pathological study. In: 2018 ACR/ARHP annual meeting: ACR; 2018. Zimba O, editor. Cardiac involvement in systemic vasculitis: a retrospective pathological study. In: 2018 ACR/ARHP annual meeting: ACR; 2018.
16.
go back to reference Senzaki H. The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases. Arch Dis Child. 2006;91(10):847–51.PubMedPubMedCentralCrossRef Senzaki H. The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases. Arch Dis Child. 2006;91(10):847–51.PubMedPubMedCentralCrossRef
17.
go back to reference Markis JE, Joffe CD, Cohn PF, Feen DJ, Herman MV, Gorlin R. Clinical significance of coronary arterial ectasia. Am J Cardiol. 1976;37(2):217–22.PubMedCrossRef Markis JE, Joffe CD, Cohn PF, Feen DJ, Herman MV, Gorlin R. Clinical significance of coronary arterial ectasia. Am J Cardiol. 1976;37(2):217–22.PubMedCrossRef
19.
go back to reference Emmi G, Silvestri E, Squatrito D, Amedei A, Niccolai E, D’Elios MM, et al. Thrombosis in vasculitis: from pathogenesis to treatment. Thromb J. 2015;13(1):15.PubMedPubMedCentralCrossRef Emmi G, Silvestri E, Squatrito D, Amedei A, Niccolai E, D’Elios MM, et al. Thrombosis in vasculitis: from pathogenesis to treatment. Thromb J. 2015;13(1):15.PubMedPubMedCentralCrossRef
20.
21.
go back to reference van der Wal AC, Becker AE. Atherosclerotic plaque rupture–pathologic basis of plaque stability and instability. Cardiovasc Res. 1999;41(2):334–44.PubMedCrossRef van der Wal AC, Becker AE. Atherosclerotic plaque rupture–pathologic basis of plaque stability and instability. Cardiovasc Res. 1999;41(2):334–44.PubMedCrossRef
22.
go back to reference Broncano J, Vargas D, Bhalla S, Cummings KW, Raptis CA, Luna A. CT and MR imaging of cardiothoracic vasculitis. Radiographics. 2018;38(4):997–1021.PubMedCrossRef Broncano J, Vargas D, Bhalla S, Cummings KW, Raptis CA, Luna A. CT and MR imaging of cardiothoracic vasculitis. Radiographics. 2018;38(4):997–1021.PubMedCrossRef
23.
go back to reference Parry S, Clark D, Campbell J. Coronary arteritis in Wegener’s granulomatosis causing fatal myocardial infarction. Hosp Med. 2000;61(4):284–5.PubMedCrossRef Parry S, Clark D, Campbell J. Coronary arteritis in Wegener’s granulomatosis causing fatal myocardial infarction. Hosp Med. 2000;61(4):284–5.PubMedCrossRef
24.
go back to reference Pagnoux C, Guillevin L. Cardiac involvement in small and medium-sized vessel vasculitides. Lupus. 2005;14(9):718–22.PubMedCrossRef Pagnoux C, Guillevin L. Cardiac involvement in small and medium-sized vessel vasculitides. Lupus. 2005;14(9):718–22.PubMedCrossRef
25.
go back to reference Vitarelli A, Capotosto L, Rosato E, Salsano F. Echocardiographic myocardial imaging reveals segmental cardiomyopathy in churg-strauss syndrome. Texas Heart Inst J. 2010;37(5):594. Vitarelli A, Capotosto L, Rosato E, Salsano F. Echocardiographic myocardial imaging reveals segmental cardiomyopathy in churg-strauss syndrome. Texas Heart Inst J. 2010;37(5):594.
26.
go back to reference Hirose O, Misawa H, Kijima Y, Yamada O, Arakaki Y, Kajino Y, et al. Two-dimensional echocardiography of coronary artery in Kawasaki disease (MCLS): detection, changes in acute phase, and follow-up observation of the aneurysm (author’s transl). J Cardiogr. 1981;11(1):89.PubMed Hirose O, Misawa H, Kijima Y, Yamada O, Arakaki Y, Kajino Y, et al. Two-dimensional echocardiography of coronary artery in Kawasaki disease (MCLS): detection, changes in acute phase, and follow-up observation of the aneurysm (author’s transl). J Cardiogr. 1981;11(1):89.PubMed
27.
go back to reference Gullo AL, Rodríguez-Carrio J, Gallizzi R, Imbalzano E, Squadrito G, Mandraffino G. Speckle tracking echocardiography as a new diagnostic tool for an assessment of cardiovascular disease in rheumatic patients. Prog Cardiovasc Dis. 2020;63:327–40.PubMedCrossRef Gullo AL, Rodríguez-Carrio J, Gallizzi R, Imbalzano E, Squadrito G, Mandraffino G. Speckle tracking echocardiography as a new diagnostic tool for an assessment of cardiovascular disease in rheumatic patients. Prog Cardiovasc Dis. 2020;63:327–40.PubMedCrossRef
28.
go back to reference Yu W, Wong SJ, Cheung Y. Left ventricular mechanics in adolescents and young adults with a history of kawasaki disease: analysis by three-dimensional speckle tracking echocardiography. Echocardiography. 2014;31(4):483–91.PubMedCrossRef Yu W, Wong SJ, Cheung Y. Left ventricular mechanics in adolescents and young adults with a history of kawasaki disease: analysis by three-dimensional speckle tracking echocardiography. Echocardiography. 2014;31(4):483–91.PubMedCrossRef
29.
go back to reference Mavrogeni S, Tsirogianni A, Gialafos E, Manoussakis M. Detection of myocardial inflammation by contrast-enhanced MRI in a patient with Churg? Strauss syndrome Int J Cardiol. 2009;131(2):e54–5.PubMedCrossRef Mavrogeni S, Tsirogianni A, Gialafos E, Manoussakis M. Detection of myocardial inflammation by contrast-enhanced MRI in a patient with Churg? Strauss syndrome Int J Cardiol. 2009;131(2):e54–5.PubMedCrossRef
30.
go back to reference Tsuda E, Singhal M. Role of imaging studies in Kawasaki disease. Int J Rheum Dis. 2018;21(1):56–63.PubMedCrossRef Tsuda E, Singhal M. Role of imaging studies in Kawasaki disease. Int J Rheum Dis. 2018;21(1):56–63.PubMedCrossRef
31.
go back to reference Forte E, Aiello M, Inglese M, Infante T, Soricelli A, Tedeschi C, et al. Coronary artery aneurysms detected by computed tomography coronary angiography. Eur Heart J Cardiovasc Imaging. 2017;18(11):1229–35.PubMedCrossRef Forte E, Aiello M, Inglese M, Infante T, Soricelli A, Tedeschi C, et al. Coronary artery aneurysms detected by computed tomography coronary angiography. Eur Heart J Cardiovasc Imaging. 2017;18(11):1229–35.PubMedCrossRef
32.
go back to reference Soto ME, Meléndez-Ramírez G, Kimura-Hayama E, Meave-Gonzalez A, Achenbach S, Herrera MC, et al. Coronary CT angiography in Takayasu arteritis. JACC Cardiovasc Imaging. 2011;4(9):958–66.PubMedCrossRef Soto ME, Meléndez-Ramírez G, Kimura-Hayama E, Meave-Gonzalez A, Achenbach S, Herrera MC, et al. Coronary CT angiography in Takayasu arteritis. JACC Cardiovasc Imaging. 2011;4(9):958–66.PubMedCrossRef
33.
go back to reference Greil GF, Stuber M, Botnar RM, Kissinger KV, Geva T, Newburger JW, et al. Coronary magnetic resonance angiography in adolescents and young adults with Kawasaki disease. Circulation. 2002;105(8):908–11.PubMedCrossRef Greil GF, Stuber M, Botnar RM, Kissinger KV, Geva T, Newburger JW, et al. Coronary magnetic resonance angiography in adolescents and young adults with Kawasaki disease. Circulation. 2002;105(8):908–11.PubMedCrossRef
34.
go back to reference Woodard PK, Li D, Haacke EM, Dhawale PJ, Kaushikkar S, Barzilai B, et al. Detection of coronary stenoses on source and projection images using three-dimensional MR angiography with retrospective respiratory gating: preliminary experience. AJR Am J Roentgenol. 1998;170(4):883–8.PubMedCrossRef Woodard PK, Li D, Haacke EM, Dhawale PJ, Kaushikkar S, Barzilai B, et al. Detection of coronary stenoses on source and projection images using three-dimensional MR angiography with retrospective respiratory gating: preliminary experience. AJR Am J Roentgenol. 1998;170(4):883–8.PubMedCrossRef
35.
go back to reference Raman SV, Aneja A, Jarjour WN. CMR in inflammatory vasculitis. J Cardiovasc Mag Reson. 2012;14(1):82.CrossRef Raman SV, Aneja A, Jarjour WN. CMR in inflammatory vasculitis. J Cardiovasc Mag Reson. 2012;14(1):82.CrossRef
36.
go back to reference Huang HL, Fong W, Peh WM, Niraj KA, Lam WW. The utility of FDG PET/CT in IgG4-related disease with a focus on coronary artery involvement. Nuclear Med Mol Imaging. 2018;52(1):53–61.CrossRef Huang HL, Fong W, Peh WM, Niraj KA, Lam WW. The utility of FDG PET/CT in IgG4-related disease with a focus on coronary artery involvement. Nuclear Med Mol Imaging. 2018;52(1):53–61.CrossRef
37.
go back to reference Treglia G, Mattoli MV, Leccisotti L, Ferraccioli G, Giordano A. Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review. Clin Rheumatol. 2011;30(10):1265.PubMedCrossRef Treglia G, Mattoli MV, Leccisotti L, Ferraccioli G, Giordano A. Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review. Clin Rheumatol. 2011;30(10):1265.PubMedCrossRef
38.
go back to reference Bleeker-Rovers C, Bredie S, Van Der Meer J, Corstens F, Oyen W. F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Neth J Med. 2003;61(10):323–9.PubMed Bleeker-Rovers C, Bredie S, Van Der Meer J, Corstens F, Oyen W. F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Neth J Med. 2003;61(10):323–9.PubMed
39.
go back to reference James OG, Christensen JD, Wong TZ, Borges-Neto S, Koweek LM. Utility of FDG PET/CT in inflammatory cardiovascular disease. Radiographics. 2011;31(5):1271–86.PubMedCrossRef James OG, Christensen JD, Wong TZ, Borges-Neto S, Koweek LM. Utility of FDG PET/CT in inflammatory cardiovascular disease. Radiographics. 2011;31(5):1271–86.PubMedCrossRef
40.
go back to reference Topaz O, Rutherford MS, Mackey-Bojack S, Prinz AW, Katta S, Salter D, et al. Giant aneurysms of coronary arteries and saphenous vein grafts: angiographic findings and histopathological correlates. Cardiovasc Pathol. 2005;14(6):298–302.PubMedCrossRef Topaz O, Rutherford MS, Mackey-Bojack S, Prinz AW, Katta S, Salter D, et al. Giant aneurysms of coronary arteries and saphenous vein grafts: angiographic findings and histopathological correlates. Cardiovasc Pathol. 2005;14(6):298–302.PubMedCrossRef
41.
go back to reference Aqel RA, Zoghbi GJ, Iskandrian A. Spontaneous coronary artery dissection, aneurysms, and pseudoaneurysms: a review. Echocardiography. 2004;21(2):175–82.PubMedCrossRef Aqel RA, Zoghbi GJ, Iskandrian A. Spontaneous coronary artery dissection, aneurysms, and pseudoaneurysms: a review. Echocardiography. 2004;21(2):175–82.PubMedCrossRef
42.
go back to reference Porto I, MacDonald S, Banning A. Intravascular ultrasound as a significant tool for diagnosis and management of coronary aneurysms. Cardiovasc Interv Radiol. 2004;27(6):666–8.CrossRef Porto I, MacDonald S, Banning A. Intravascular ultrasound as a significant tool for diagnosis and management of coronary aneurysms. Cardiovasc Interv Radiol. 2004;27(6):666–8.CrossRef
43.
go back to reference Freeman AF, Shulman ST. Kawasaki disease: summary of the American Heart Association guidelines. Am Fam Phys. 2006;74(7):1141–8. Freeman AF, Shulman ST. Kawasaki disease: summary of the American Heart Association guidelines. Am Fam Phys. 2006;74(7):1141–8.
44.
go back to reference Kawsara A, Gil IJN, Alqahtani F, Moreland J, Rihal CS, Alkhouli M. Management of coronary artery aneurysms. JACC Cardiovasc Interv. 2018;11(13):1211–23.PubMedCrossRef Kawsara A, Gil IJN, Alqahtani F, Moreland J, Rihal CS, Alkhouli M. Management of coronary artery aneurysms. JACC Cardiovasc Interv. 2018;11(13):1211–23.PubMedCrossRef
45.
go back to reference Fernandez-Cooke E, Barrios Tascón A, Sánchez-Manubens J, Antón J, Grasa Lozano CD, Aracil Santos J, et al. Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development (2011–2016): KAWA-RACE study group. PLoS ONE. 2019;14(5):e0215665.PubMedPubMedCentralCrossRef Fernandez-Cooke E, Barrios Tascón A, Sánchez-Manubens J, Antón J, Grasa Lozano CD, Aracil Santos J, et al. Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development (2011–2016): KAWA-RACE study group. PLoS ONE. 2019;14(5):e0215665.PubMedPubMedCentralCrossRef
46.
go back to reference Chen S, Dong Y, Yin Y, Krucoff MW. Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis. Heart. 2013;99(2):76–82.PubMedCrossRef Chen S, Dong Y, Yin Y, Krucoff MW. Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis. Heart. 2013;99(2):76–82.PubMedCrossRef
47.
go back to reference McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927–99.PubMedCrossRef McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927–99.PubMedCrossRef
48.
go back to reference Sleeper LA, Minich LL, McCrindle BM, Li JS, Mason W, Colan SD, et al. Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr. 2011;158(5):831–5.PubMedCrossRef Sleeper LA, Minich LL, McCrindle BM, Li JS, Mason W, Colan SD, et al. Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr. 2011;158(5):831–5.PubMedCrossRef
49.
go back to reference Gülec S, Aras Ö, Atmaca Y, Akyürek Ö, Hanson N, Sayin T, et al. Deletion polymorphism of the angiotensin I converting enzyme gene is a potent risk factor for coronary artery ectasia. Heart. 2003;89(2):213–4.PubMedPubMedCentralCrossRef Gülec S, Aras Ö, Atmaca Y, Akyürek Ö, Hanson N, Sayin T, et al. Deletion polymorphism of the angiotensin I converting enzyme gene is a potent risk factor for coronary artery ectasia. Heart. 2003;89(2):213–4.PubMedPubMedCentralCrossRef
50.
go back to reference Krüger D, Stierle U, Herrmann G, Simon R, Sheikhzadeh A. Exercise-induced myocardial ischemia in isolated coronary artery ectasias and aneurysms (“dilated coronaropathy”). J Am Coll Cardiol. 1999;34(5):1461–70.PubMedCrossRef Krüger D, Stierle U, Herrmann G, Simon R, Sheikhzadeh A. Exercise-induced myocardial ischemia in isolated coronary artery ectasias and aneurysms (“dilated coronaropathy”). J Am Coll Cardiol. 1999;34(5):1461–70.PubMedCrossRef
51.
go back to reference Harandi S, Johnston SB, Wood RE, Roberts WC. Operative therapy of coronary arterial aneurysm. Am J Cardiol. 1999;83(8):1290–3.PubMedCrossRef Harandi S, Johnston SB, Wood RE, Roberts WC. Operative therapy of coronary arterial aneurysm. Am J Cardiol. 1999;83(8):1290–3.PubMedCrossRef
52.
go back to reference Ohtsuka M, Uchida E, Yamaguchi H, Nakajima T, Akazawa H, Funabashi N, et al. Coronary aneurysm reduced after coronary stenting. Int J Cardiol. 2007;121(1):76–7.PubMedCrossRef Ohtsuka M, Uchida E, Yamaguchi H, Nakajima T, Akazawa H, Funabashi N, et al. Coronary aneurysm reduced after coronary stenting. Int J Cardiol. 2007;121(1):76–7.PubMedCrossRef
53.
go back to reference Alfonso F, Pérez-Vizcayno M-J, Ruiz M, Suárez A, Cazares M, Hernández R, et al. Coronary aneurysms after drug-eluting stent implantation: clinical, angiographic, and intravascular ultrasound findings. J Am Coll Cardiol. 2009;53(22):2053–60.PubMedCrossRef Alfonso F, Pérez-Vizcayno M-J, Ruiz M, Suárez A, Cazares M, Hernández R, et al. Coronary aneurysms after drug-eluting stent implantation: clinical, angiographic, and intravascular ultrasound findings. J Am Coll Cardiol. 2009;53(22):2053–60.PubMedCrossRef
54.
go back to reference Joo HJ, Woong YuC, Choi R, Park J, Lee HJ, Kim JS, et al. Clinical outcomes of patients with coronary artery aneurysm after the first generation drug-eluting stent implantation. Catheter Cardiovasc Interv. 2018;92(3):E235–45.PubMedCrossRef Joo HJ, Woong YuC, Choi R, Park J, Lee HJ, Kim JS, et al. Clinical outcomes of patients with coronary artery aneurysm after the first generation drug-eluting stent implantation. Catheter Cardiovasc Interv. 2018;92(3):E235–45.PubMedCrossRef
55.
go back to reference Abou Sherif S, Ozden Tok O, Taşköylü Ö, Goktekin O, Kilic ID. Coronary artery aneurysms: a review of the epidemiology, pathophysiology, diagnosis, and treatment. Front Cardiovasc Med. 2017;4:24.PubMedPubMedCentralCrossRef Abou Sherif S, Ozden Tok O, Taşköylü Ö, Goktekin O, Kilic ID. Coronary artery aneurysms: a review of the epidemiology, pathophysiology, diagnosis, and treatment. Front Cardiovasc Med. 2017;4:24.PubMedPubMedCentralCrossRef
56.
go back to reference LaMotte LC, Mathur VS. Atherosclerotic coronary artery aneurysms: eight-year angiographic follow-up. Texas Heart Inst J. 2000;27(1):72. LaMotte LC, Mathur VS. Atherosclerotic coronary artery aneurysms: eight-year angiographic follow-up. Texas Heart Inst J. 2000;27(1):72.
57.
go back to reference Sugahara Y, Ishii M, Muta H, Iemura M, Matsuishi T, Kato H. Warfarin therapy for giant aneurysm prevents myocardial infarction in Kawasaki disease. Pediatr Cardiol. 2008;29(2):398–401.PubMedCrossRef Sugahara Y, Ishii M, Muta H, Iemura M, Matsuishi T, Kato H. Warfarin therapy for giant aneurysm prevents myocardial infarction in Kawasaki disease. Pediatr Cardiol. 2008;29(2):398–401.PubMedCrossRef
58.
go back to reference Doi T, Kataoka Y, Noguchi T, Shibata T, Nakashima T, Kawakami S, et al. Coronary artery ectasia predicts future cardiac events in patients with acute myocardial infarction. Arterioscler Thromb Vasc Biol. 2017;37(12):2350–5.PubMedCrossRef Doi T, Kataoka Y, Noguchi T, Shibata T, Nakashima T, Kawakami S, et al. Coronary artery ectasia predicts future cardiac events in patients with acute myocardial infarction. Arterioscler Thromb Vasc Biol. 2017;37(12):2350–5.PubMedCrossRef
59.
go back to reference Edwards N, Ferro C, Townend J, Steeds R. Myocardial disease in systemic vasculitis and autoimmune disease detected by cardiovascular magnetic resonance. Rheumatology. 2007;46:1208–9.PubMedCrossRef Edwards N, Ferro C, Townend J, Steeds R. Myocardial disease in systemic vasculitis and autoimmune disease detected by cardiovascular magnetic resonance. Rheumatology. 2007;46:1208–9.PubMedCrossRef
60.
go back to reference Kitamura S, Tsuda E, Kobayashi J, Nakajima H, Yoshikawa Y, Yagihara T, et al. Twenty-five-year outcome of pediatric coronary artery bypass surgery for Kawasaki disease. Circulation. 2009;120(1):60.PubMedCrossRef Kitamura S, Tsuda E, Kobayashi J, Nakajima H, Yoshikawa Y, Yagihara T, et al. Twenty-five-year outcome of pediatric coronary artery bypass surgery for Kawasaki disease. Circulation. 2009;120(1):60.PubMedCrossRef
61.
go back to reference Tirilomis T, Steinmetz M, Grossmann M, Bräuer A, Paul T, Ruschewski W, et al. Heart transplantation in a toddler with cardiac Kawasaki disease. Front Surg. 2017;4:21.PubMedPubMedCentralCrossRef Tirilomis T, Steinmetz M, Grossmann M, Bräuer A, Paul T, Ruschewski W, et al. Heart transplantation in a toddler with cardiac Kawasaki disease. Front Surg. 2017;4:21.PubMedPubMedCentralCrossRef
62.
go back to reference Checchia PA, Pahl E, Shaddy RE, Shulman ST. Cardiac transplantation for Kawasaki disease. Pediatrics. 1997;100(4):695–9.PubMedCrossRef Checchia PA, Pahl E, Shaddy RE, Shulman ST. Cardiac transplantation for Kawasaki disease. Pediatrics. 1997;100(4):695–9.PubMedCrossRef
63.
go back to reference Chaudhary H, Nameirakpam J, Kumrah R, Pandiarajan V, Suri D, Rawat A, et al. Biomarkers for Kawasaki disease: clinical utility and the challenges ahead. Front Pediatr. 2019;7:242.PubMedPubMedCentralCrossRef Chaudhary H, Nameirakpam J, Kumrah R, Pandiarajan V, Suri D, Rawat A, et al. Biomarkers for Kawasaki disease: clinical utility and the challenges ahead. Front Pediatr. 2019;7:242.PubMedPubMedCentralCrossRef
64.
go back to reference Dominguez SR, Martin B, Heizer H, Jone P-N, Tong S, Davidson J, et al. Procalcitonin (PCT) and Kawasaki disease: does PCT correlate with IVIG-resistant disease, admission to the intensive care unit, or development of coronary artery lesions? J Pediatr Infect Dis Soc. 2016;5(3):297–302.CrossRef Dominguez SR, Martin B, Heizer H, Jone P-N, Tong S, Davidson J, et al. Procalcitonin (PCT) and Kawasaki disease: does PCT correlate with IVIG-resistant disease, admission to the intensive care unit, or development of coronary artery lesions? J Pediatr Infect Dis Soc. 2016;5(3):297–302.CrossRef
65.
go back to reference Lee NH, Choi HJ, Kim YH. Clinical usefulness of serum procalcitonin level in distinguishing between Kawasaki disease and other infections in febrile children. Korean J Pediatr. 2017;60(4):112.PubMedPubMedCentralCrossRef Lee NH, Choi HJ, Kim YH. Clinical usefulness of serum procalcitonin level in distinguishing between Kawasaki disease and other infections in febrile children. Korean J Pediatr. 2017;60(4):112.PubMedPubMedCentralCrossRef
66.
go back to reference Panja M, Sarkar C, Kar A, Kumar S, Mazumder B, Roy S, et al. Coronary artery lesions in Takayasu’s arteritis–clinical and angiographic study. J Assoc Phys India. 1998;46(8):678–81. Panja M, Sarkar C, Kar A, Kumar S, Mazumder B, Roy S, et al. Coronary artery lesions in Takayasu’s arteritis–clinical and angiographic study. J Assoc Phys India. 1998;46(8):678–81.
67.
go back to reference Pan L, Du J, Liu J, Liao H, Liu X, Guo X, et al. Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis. Clin Rheumatol. 2020;39:2369–78.PubMedCrossRef Pan L, Du J, Liu J, Liao H, Liu X, Guo X, et al. Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis. Clin Rheumatol. 2020;39:2369–78.PubMedCrossRef
68.
go back to reference Ohigashi H, Haraguchi G, Konishi M, Tezuka D, Kamiishi T, Ishihara T, et al. Improved prognosis of Takayasu arteritis over the past decade. Circ J. 2012;76:1004.PubMedCrossRef Ohigashi H, Haraguchi G, Konishi M, Tezuka D, Kamiishi T, Ishihara T, et al. Improved prognosis of Takayasu arteritis over the past decade. Circ J. 2012;76:1004.PubMedCrossRef
69.
go back to reference Maksimowicz-McKinnon K, Clark TM, Hoffman GS. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum. 2007;56(3):1000–9.PubMedCrossRef Maksimowicz-McKinnon K, Clark TM, Hoffman GS. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum. 2007;56(3):1000–9.PubMedCrossRef
71.
go back to reference Merkel PA, Matteson ELE, Curtis MRE. Treatment of Takayasu arteritis. UpToDate, Waltham, MA. Last accessed 04 Oct 2020. Merkel PA, Matteson ELE, Curtis MRE. Treatment of Takayasu arteritis. UpToDate, Waltham, MA. Last accessed 04 Oct 2020.
72.
go back to reference Merkel PA, Matteson ELE, Curtis MRE. Treatment and prognosis of polyarteritis nodosa. UpToDate, Waltham, MA. Last accessed 07 April 2020. Merkel PA, Matteson ELE, Curtis MRE. Treatment and prognosis of polyarteritis nodosa. UpToDate, Waltham, MA. Last accessed 07 April 2020.
73.
go back to reference Guillevin L, Cohen P, Mahr A, Arène JP, Mouthon L, Puéchal X, et al. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Care Res Off J Am Coll Rheumatol. 2003;49(1):93–100.CrossRef Guillevin L, Cohen P, Mahr A, Arène JP, Mouthon L, Puéchal X, et al. Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Care Res Off J Am Coll Rheumatol. 2003;49(1):93–100.CrossRef
74.
go back to reference Yanagawa B, Kumar P, Tsuneyoshi H, Kachel E, Massad E, Moussa F, et al. Coronary artery bypass in the context of polyarteritis nodosa. Ann Thorac Surg. 2010;89(2):623–5.PubMedCrossRef Yanagawa B, Kumar P, Tsuneyoshi H, Kachel E, Massad E, Moussa F, et al. Coronary artery bypass in the context of polyarteritis nodosa. Ann Thorac Surg. 2010;89(2):623–5.PubMedCrossRef
75.
go back to reference Yamamoto Y, Iino K, Ueda H, No H, Nishida Y, Takago S, et al. Coronary artery bypass grafting in a patient with polyarteritis nodosa. Ann Thorac Surg. 2017;103(5):e431–3.PubMedCrossRef Yamamoto Y, Iino K, Ueda H, No H, Nishida Y, Takago S, et al. Coronary artery bypass grafting in a patient with polyarteritis nodosa. Ann Thorac Surg. 2017;103(5):e431–3.PubMedCrossRef
76.
go back to reference Mednick Z, Farmer J, Khan Z, Warder D, Ten Hove M. Coronary arteritis: an entity to be considered in giant cell arteritis. Can J Ophthalmol. 2016;51(1):e6–8.PubMedCrossRef Mednick Z, Farmer J, Khan Z, Warder D, Ten Hove M. Coronary arteritis: an entity to be considered in giant cell arteritis. Can J Ophthalmol. 2016;51(1):e6–8.PubMedCrossRef
77.
go back to reference Tomasson G, Peloquin C, Mohammad A, Love TJ, Zhang Y, Choi HK, et al. Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study. Ann Intern Med. 2014;160(2):73–80.PubMedPubMedCentralCrossRef Tomasson G, Peloquin C, Mohammad A, Love TJ, Zhang Y, Choi HK, et al. Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study. Ann Intern Med. 2014;160(2):73–80.PubMedPubMedCentralCrossRef
78.
go back to reference Villiger PM, Adler S, Kuchen S, Wermelinger F, Dan D, Fiege V, et al. Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet. 2016;387(10031):1921–7.PubMedCrossRef Villiger PM, Adler S, Kuchen S, Wermelinger F, Dan D, Fiege V, et al. Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet. 2016;387(10031):1921–7.PubMedCrossRef
79.
go back to reference Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, et al. Trial of tocilizumab in giant-cell arteritis. N Engl J Med. 2017;377(4):317–28.PubMedCrossRef Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, et al. Trial of tocilizumab in giant-cell arteritis. N Engl J Med. 2017;377(4):317–28.PubMedCrossRef
80.
go back to reference Docken WP, Trobe JE, Matteson ELE, Curtis MRE. Treatment of giant cell arteritis. UpToDate, Waltham, MA. Last accessed on 04 Oct 2020. Docken WP, Trobe JE, Matteson ELE, Curtis MRE. Treatment of giant cell arteritis. UpToDate, Waltham, MA. Last accessed on 04 Oct 2020.
Metadata
Title
Coronary artery vasculitis: a review of current literature
Authors
Shaun Khanna
Kartheek Garikapati
Daniel S. L. Goh
Kenneth Cho
Phillip Lo
Mohan V. Bhojaraja
Surjit Tarafdar
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2021
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-020-01813-6

Other articles of this Issue 1/2021

BMC Cardiovascular Disorders 1/2021 Go to the issue